Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT00871169
Title Combination of Irinotecan, Oxaliplatin and Cetuximab for Locally Advanced or Metastatic Pancreatic Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors New Mexico Cancer Care Alliance
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of New Mexico Cancer Center @ Lovelace Medical Center Albuquerque New Mexico 87102 United States Details
Hematology Oncology Associates Albuquerque New Mexico 87106 United States Details
Cancer Center at Presbyterian Hospital Albuquerque New Mexico 87110 United States Details
University of New Mexico Cancer Center Albuquerque New Mexico 87131-0001 United States Details
Memorial Medical Center- Cancer Center Las Cruces New Mexico 88011 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field